Asymchem is a global CDMO offering integrated solutions across all stages of drug development and into commercialization.
600 Airport Blvd Ste. 1000
Morrisville, NC 27560
1 919.468.3884
[email protected]
https://www.asymchem.com
Asymchem
By continually embracing technological advances that drive efficiency, safety and sustainability, we deliver smarter, greener, and more cost-effective development and manufacturing. Experience the CDMO of tomorrow for maximum competitive advantage today.
Bellen Chem
Bellen is a manufacturer, highly focused on heterocyclic chemistry with great innovative research capabilities. In the last decade our innovative research capabilities have attracted the attention of a large number of important international companies…
Address
No. 1 Caida 3rd StreetMaoHua Garden
ShunYi District
Beijing, 101300
China
Phone
(+86) 10 60400362
Website
http://www.bellenchem.com/
Bellen Chem
Bellen is a manufacturer, highly focused on heterocyclic chemistry with great innovative research capabilities. In the last decade our innovative research capabilities have attracted the attention of a large number of important international companies, and we have subsequently developed FTE, CRO and CDMO services to support them. Bellen is committed to continue investing into innovation and build state-of-the art facilities to enable a “one-stop-shop” chemistry service platform for the pharmaceutical and biotech industries
Eurofins CDMO Alphora Inc., operating as part of Eurofins CDMO, is a leading provider of Active Pharmaceutical Ingredient and Drug Product development and manufacturing services for complex small molecules,
Address
2395 Speakman Drive,
Suite 2001,
Mississauga,
Ontario
L5K 1B3
Phone
+1-905-403-0477
Website
https://www.eurofins.com/cdmo
Eurofins CDMO
Eurofins CDMO Alphora Inc., operating as part of Eurofins CDMO, is a leading provider of Active Pharmaceutical Ingredient and Drug Product development and manufacturing services for complex small molecules, including highly potent compounds. As a campus style facility, we offer API and Drug Product Development services as a fully integrated solution or as stand-alone services.
Kaneka has established itself as a leading global manufacturer of pharmaceutical RSM, intermediates and API, especially in the field of difficult to make chiral compounds. Our technology based approach to manufacturing includes over 35 years of experience using enzyme mediated synthesis and fermentation technologies and 6 years of Flow Chemistry development and manufacturing, including our FDA inspected GMP Flow Chemistry facility in Singapore. Finding the best Flow setup or Enzymatic transformation for your chemistry from g to MT is our commercial specialty, including fast and efficient scale-up of these approaches.
546 Fifth Avenue, 21st Floor
New York, NY 10036
T: 646.573.2069
Kaneka Americas Holding, Inc.
Utilizing enzyme mediated synthesis and fermentation technologies along with a variety of advanced organic synthetic techniques, including flow chemistry, Kaneka has established itself as a leading manufacturer of pharmaceutical bulk, intermediates and fine chemicals, especially in the field of chiral compounds. For more information visit www.fcd.kaneka.co.jp
https://www.pfizer.co.uk/
Pfizer
Our site within Discovery Park, in Sandwich, UK, is a co-home (with Groton, CT, USA) to our Medicinal Sciences, Pharmaceutical Sciences Small Molecule team. This team uses its specialist expertise to turn experimental molecules into the liquid and solid dose medicines used in clinical trials.
PharmaBlock Sciences (Nanjing), Inc. is a leading innovative chemistry products and services provider throughout the pharmaceutical R&D process.
10 Xuefu Road, Nanjing Hi-tech Zone,
NanjingJiangsu
Province
210032, China
PharmaBlock
Its core businesses include: a catalog of specially designed scaffolds and building blocks; custom synthesis; process R&D; pilot plant and manufacturing of key intermediates and RSMs; and FTE services.It has a manufacturing site of 861,100 sq ft located in Shandong Province.
Phlow Corp. is a U.S. -based innovative essential medicines impact company that is reimagining the essential medicine supply chain through innovation in how these medicines are manufactured.
1001 Haxall Point #1B
Richmond, VA 23219
+1 (804) 207-4893
[email protected]
https://www.phlow-usa.com
Phlow Corp.
Phlow Corp. is a U.S. -based innovative essential medicines impact company that is reimagining the essential medicine supply chain through innovation in how these medicines are manufactured. Founded in 2020, Phlow is committed to securing the nation with a predictable and stable domestic supply of essential medicines. Phlow is working to establish a resilient end-to-end solution that is U.S.-based, comprehensive, and fully integrated so no patient visits a hospital to find out that the medicine they need is not available. With the support of an exceptional team, experienced strategic partners, and established relationships at the policy, regulatory, and federal levels, Phlow will manufacture APIs and finished pharmaceutical products domestically for essential medicines critical to the future of healthcare. Using state-of-the-art green chemistry, continuous flow technology, and other advanced manufacturing processes, Phlow is able to reduce costs and waste, improve quality and yield, and offer a more environmentally friendly alternative to batch manufacturing
Mere Way,
Ruddington,
Nottingham
NG11 6JS
+44 (0)115 974 9000 / U.S. +1 800 769 3518,
https://www.quotientsciences.com/
Quotient Sciences
Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients.
Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast.
No3, Binhai
10th Road North,
Shihua Dadao Middle,
DayaBay,
Huizhou,
Guangdong, China
[email protected]
http://www.rafflespt.com/
Raffles Pharmatech Co., Ltd
Founded in Aug,2011, Raffles has been taking Chemical synthesis as the core, committing to provide small molecule drugs clients with starting materials, intermediates and API customized research development and manufacturing services from discovery phase until commercial production, providing customers with the reliable solutions of taking cost, innovation, and speed into consideration, served more than 200 domestic and foreign innovative drug customers. What’s more, Raffles provides in-depth services, engages and supports the R&D and production of innovative drugs around the world, and promote the green, efficient industrialization and rapid marketing of innovative drugs to the benefit of patients.
Technobis Crystallization Systems is a world leading technology provider for solid-state research, process development and formulation.
Pyrietstraat 2
1812SC Alkmaar
The Netherlands
T: +1 563 564 1988
W: https://www.crystallizationsystems.com/home
Technobis
Our mission is to make researchers all over the world more successful by providing smart and fast solutions, based on our unique technology, knowledge and expertise.
Arcinova is a UK-based Contract Development and Manufacturing Organisation (CDMO) serving the global pharmaceutical and biotechnology communities.
Taylor Drive
Alnwick
Northumberland
United Kingdom
NE66 2DH
+44 (0) 1665 608 567 – Office
arcinova.uk
Arcinova
Arcinova is a UK-based Contract Development and Manufacturing Organisation (CDMO) serving the global pharmaceutical and biotechnology communities.
From our single 15,000m2 facility, which has benefited from more than 36 years of investment as a key R&D centre for Sanofi and Covance, we can support our clients’ needs with a wide range of services such as: drug substance development and manufacturing (including GMP, [14C]-labelled products and high potents), material sciences, formulation and drug product manufacturing.
We can manufacture both drug substance and drug products from grams to multi-kilo scale.
We also offer supporting analytical services including, investigations and development of QC specifications, microbiological and stability testing as well as a regulatory CMC dossier writing service.
Finally, our experienced bioanalytical team can develop, validate and implement bioanalytical assays for small and large molecule drugs, generics and biomarkers to support both clinical and non-clinical studies.
Binger Strasse 173
55216 Ingelheim am Rhein
+49 – 6132 – 77 0
[email protected]
https://www.boehringer-ingelheim.com/
Boegringer Ingelheim
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Learn more at www.boehringer-ingelheim.com
Chemtrix BV combines expertise in the field of (chemical) engineering and chemistry to help their customers to benefit from Flow Chemistry.
Chemtrix BV Headquarters
Chemelot Campus, Gate 2, Building 110
Urmonderbaan 22
6167 RD Geleen
The Netherlands
T: 0031 (0) 46 70 22 600
F: 0031 (0) 46 70 22 603
Chemtrix
Chemtrix BV combines expertise in the field of (chemical) engineering and chemistry to help their customers to benefit from Flow Chemistry. Their expertise enables them to offer scalable and flexible Flow Chemistry solutions. Chemtrix focuses on delivering the customer higher profits by accessing new chemical possibilities, via a safe and reliable scale-up from lab to production.
Huber
Huber UK and Ireland Ltd is a wholly owned subsidiary of Peter Huber Kaltemaschinenbau AG a technology leader for high precision thermoregulation solutions in research and industry….
Huber UK & Ireland Ltd
Unit 7, Heritage Business Centre
Derby rd
Belper DE56 1SW
Contact Phone: +44 1773 82 3369
Website: www.huber-uk.co.uk
Email: [email protected]
Huber
With service and store facilities in Derbyshire and Dublin, Huber UK and Ireland are ideally situated to support your application form small to large scale chemistry. Our products ensure precise temperature control in laboratories, pilot plants and production processes throughout the whole world – from -125 °C to +425 °C. Besides dynamic temperature control systems we develop and produce chillers as well as classic heating and cooling circulators. For many applications we supply custom-tailored solutions, which we develop in cooperation with our customers.
Accelerate to the next phase with our advanced catalyst and ligand technologies.
820 Bear Tavern Road
West Trenton
New Jersey
08629
USA
W: http://en.sinocompound.com/
E: [email protected]
Sinocompound
Sinocompound is a global provider of advanced homogeneous catalysts and ligands and specialist services for a range of pharmaceutical and fine chemical applications. Our proven process is built around our next generation technologies, flexibility, and speed-of-response ensuring delivery at the scale required for your project. Our success is due to our dedication to listening to customers and developing bespoke solutions that help the industry overcome its challenges and customers accelerate their route to market.
SK pharmteco specializes in the commercial and clinical production of APIs, Advanced Intermediates, Registered Starting Materials, Key Building Blocks and Viral Vectors. Our offerings include process R&D, analytical method development and stability, scale-up and optimization, validation and commercial production.
SK Pharmteco
Profile
SK pharmteco specializes in the commercial and clinical production of APIs, Advanced Intermediates, Registered Starting Materials, Key Building Blocks and Viral Vectors. Our offerings include process R&D, analytical method development and stability, scale-up and optimization, validation and commercial production. Additionally, we offer extensive AAV and Lentiviral vector development and cGMP production capabilities.
Our global operations include 7 cGMP manufacturing and development facilities across the US, Korea, Ireland and France. We also operate a dedicated analytical services facility.
SK pharmteco is a leader in operational excellence and continuous improvement. Our highly skilled team delivers innovative solutions utilizing advanced technologies:
– Continuous Flow Processing
– Chromatography: SMB & Batch
– High Potency (Up to 4 m³ scale & down to 10 ng/m³
containment)
– Energetic Chemistry
– Controlled Substances (Sch II-V Manufacturing)
– Particle Engineering
– cGMP Manufacturing in Adherent & Suspension Systems for
Viral Vectors
– Analytical & Process Development for Viral Vectors
We have a strong record of environmental, health, and safety performance. All our plants have been successfully audited by global regulatory agencies including the FDA (US), EMA (Europe), PMDA (Japan), & MFDS (Korea).
Strong technology toolbox & ~1,000 m³ of global small-molecule capacity + 5k m² of large
Products & Services
– Continuous Flow Processing
– Chromatography: SMB & Batch
– High Potency (Up to 4 m³ scale & down to 10 ng/m³
containment)
– Energetic Chemistry
– Controlled Substances (Schedule II-V Manufacturing)
– Particle Engineering
– cGMP Manufacturing in Adherent & Suspension Systems for
Viral Vectors
– Analytical & Process Development for Viral Vectors
We provide PAI and full regulatory support.
Stoli Chem
Multipurpose and scalable flow reactor technologies for sustainable processes. Effortlessly taking your process from the lab to pilot to production scale.
Stoli Catalysts Ltd
Prince Phillip Building
Wellesbourne Campus
Wellesbourne
CV35 9EF
UK
Phone: 0800 145 5401
Contact Email: [email protected]
Web: https://stolicatalysts.com/
LinkedIn: https://www.linkedin.com/company/stoli-catalysts/
Stoli Chem
Design and develop scalable flow reactors to convert batch chemistry to flow.
Utilising over 15 years of experience in process design and catalysis, Stoli work closely with you to optimise production efficiency.
Our scalable multipurpose flow reactor offers a straight forward route to scale-up from lab to pilot to production scale. The modular design allows for changeable inserts to accommodate liquid-liquid, liquid-gas and solid-liquid reaction types.
Independent stirring and flow rate allow for efficient mixing even at long residence times.
Visit us to discuss how our technology can benefit your company and to organise a reactor trial.
Web: https://stolicatalysts.com/
LinkedIn: https://www.linkedin.com/company/stoli-catalysts/
Vapourtec Ltd is an innovative laboratory technology company based near Cambridge, UK
Vapourtec Ltd
21 Park Farm Business Centre
Fornham St. Genevieve
Bury St Edmunds
Suffolk
United Kingdom
IP28 6TS
T: +44 (0)1284 728659
F: +44 (0)1284 728352
E: [email protected]
W: www.vapourtec.com
Vapourtec
Vapourtec develops, manufactures and markets cutting-edge flow chemistry systems for fine chemical discovery and process development. Customers for Vapourtec’s products include blue-chip companies and research institutes developing, pharmaceuticals, agrochemicals, fragrances, advanced materials and other fine chemicals.
XtalPi is a quantum physic-based AI-powered pharmatech company that is dedicated to reinventing the industry’s approach to drug research and development.
245 Main St, 11th Floor, Cambridge, MA 02038.
781-779-9015
[email protected]
https://www.xtalpi.com/en/
XtalPi
XtalPi is a quantum physic-based AI-powered pharmatech company that is dedicated to reinventing the industry’s approach to drug research and development. XtalPi’s technology platform combines in-silico prediction with high throughput wet lab validation in an iterative cycle that empowers continuous innovation and increase efficiency, accuracy and reliability that are critical to drug R&D. XtlaPi aims to accelerate the pace of drug discovery by providing high fidelity details into the molecular foundation of tomorrow’s drug, and to contribute to a healthier society worldwide.
Founded in 2014 by a group of quantum physicists at MIT, XtalPi has since grown into an elite team of researchers with multi-disciplinary expertise in physics, chemistry, pharmaceutical R&D, and algorithm design. XtalPi has received much recognition for its cutting-edge technologies, its innovative solutions, and the breadth of potential applications of its offerings across the pharmaceutical value chain, which has allowed it to gain industry approval and establish strategic partnerships with several top international pharmaceutical companies.
